GENEDESIGN
GD operates as an oligonucleotides manufacturer with broad capacity for DNA/RNA/LNA oligonucleotide synthesis from micro mole to gram scale.
GENEDESIGN
Industry:
Biotechnology Manufacturing
Address:
Osaka, Osaka, Japan
Country:
Japan
Website Url:
http://www.genedesign.co.jp
Status:
Active
Contact:
072-640-5180
Technology used in webpage:
IPhone / Mobile Compatible SPF Mobile Non Scaleable Content NTT PC Communications InfoSphere DNS
Similar Organizations
Microdermis
Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.
Current Employees Featured
Official Site Inspections
http://www.genedesign.co.jp
- Host name: genedesign.co.jp
- IP address: 203.138.132.13
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "GeneDesign"
Ajinomoto Group Acquires All Shares of GeneDesign, Inc., a …
TOKYO, December 9, 2016 – Ajinomoto Co., Inc. (“Ajinomoto Co.”) and its consolidated subsidiary S.A. Ajinomoto OmniChem N.V. (“OmniChem”) agreed to acquire all the issued and outstanding shares of GeneDesign, Inc., a major Japanese contract development and …See details»
Aji Bio-Pharma | Ajinomoto Group Acquires All Shares of …
TOKYO, December 9th 2016 – Ajinomoto Co., Inc. (“Ajinomoto Co.”) and its consolidated subsidiary S.A. Ajinomoto OmniChem N.V. (“OmniChem”) agreed to acquire all the issued and outstanding shares of GeneDesign, Inc., a major Japanese contract development and …See details»
GeneDesign - Crunchbase Company Profile & Funding
Organization. GeneDesign . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Alternatives and possible competitors to GeneDesign may include Microdermis and Hongene Biotechnology. Unlock even more features with Crunchbase Pro . …See details»
GeneDesign joins Ajinomoto Bio-Pharma
Apr 23, 2019 GeneDesign, Japanese contract development and manufacturing organization (CDMO), held the grand opening of the facility in Osaka, Japan, on April 5, prior to CPhI North America. The 2,000m² building will improve the …See details»
GeneDesign Company Profile 2024: Valuation, …
GeneDesign General Information Description. Manufacturer and developer of oligonucleotides, based in Osaka, Japan. The company manufactures nucleic acid drugs and provides research services, enabling clients to avail quality …See details»
GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens ...
Apr 9, 2019 GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center April 9, 2019 - Osaka, Japan - Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing …See details»
Enhancing the Contract Development and Production System …
GeneDesign, which was established in 2000, is a major Japanese contract development and manufacturing organization (CDMO)3 for oligonucleotides. By making GeneDesign a consolidated subsidiary in April 2017, Ajinomoto Co. enabled integrated contract development and …See details»
GeneDesign joins Ajinomoto Bio-Pharma Services and opens an ...
Apr 9, 2019 The integration of the offer of services of GeneDesign with the capacities of small and big molecules of Aji Bio-Pharma in the EE. UU., Belgium and India strengthens the organization's commitment to its customers to be a contract development and manufacturing …See details»
Information on Service Brand Name Change - English
GeneDesign, a wholly owned Ajinomoto company, provides high quality and scalable custom oligonucleotides for the biopharmaceutical industry. The integration of GeneDesign’s services offerings with Aji Bio-Pharma’s small and large molecule capabilities in the US, Belgium and …See details»
GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens ...
Apr 8, 2019 The integration of GeneDesign's services offerings with Aji Bio-Pharma's small and large molecule capabilities in the US, Belgium and India strengthens the organization's commitment to its ...See details»
GeneDesign - Crunchbase
GD operates as an oligonucleotides manufacturer with broad capacity for DNA/RNA/LNA oligonucleotide synthesis from micro mole to gram scale.See details»
GeneDesign joins Ajinomoto Bio-pharma
GeneDesign, a wholly owned Ajinomoto company, provides high quality and scalable custom oligonucleotides for the biopharmaceutical industry. The integration of GeneDesign's services offerings with Aji Bio-Pharma's small and large molecule capabilities in the US, Belgium and …See details»
Aji Bio opens large-scale oligo production plant in Osaka
Apr 12, 2019 Facilitated by its 2016 acquisition of GeneDesign, CDMO Ajinomoto Bio-Pharma has opened a 21,500 square-foot plant in Japan to service the growing oligonucleotide demand. In December 2016, Japan’s Ajinomoto OmniChem acquired nucleic acid drug contract …See details»
Japan's Ajinomoto Bio-Pharma Services takes control of GeneDesign
Apr 15, 2019 GeneDesign was acquired by Ajinomoto Co. in 2017 but now will be under the control of its small- and large-molecule API producer, Ajinomoto Bio-Pharma Services. The deal comes as GeneDesign has ...See details»
GeneDesign Joins Ajinomoto Bio-Pharma Services, Opens …
Apr 9, 2019 GeneDesign, a wholly owned Ajinomoto company, provides high quality and scalable custom oligonucleotides for the biopharmaceutical industry. The integration of GeneDesign’s services offerings with Aji Bio-Pharma’s small and large molecule capabilities in …See details»
GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens
Apr 8, 2019 GeneDesign, a wholly owned Ajinomoto company, provides high quality and scalable custom oligonucleotides for the biopharmaceutical industry. The integration of GeneDesign's services offerings with Aji Bio-Pharma's small and large molecule capabilities in …See details»
Ajinomoto Bio-Pharma Services Platform Technologies
Oct 7, 2024 Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization (CDMO) with sites in Belgium, United States, Japan, and India, providing comprehensive development, cGMP manufacturing, and aseptic fill finish services …See details»
GeneDesign Joins Ajinomoto Bio-Pharma Services & Opens …
GeneDesign, a wholly owned Ajinomoto company, provides high quality and scalable custom oligonucleotides for the biopharmaceutical industry. The integration of GeneDesign’s services offerings with Aji Bio-Pharma’s small and large molecule capabilities in the US, Belgium and …See details»
GeneDesign 3.0 is an updated synthetic biology toolkit
Mar 8, 2010 GeneDesign is a set of web applications that provides public access to a nucleotide manipulation pipeline for synthetic biology. The server is public and freely accessible, and the source is available for download under the New BSD License. Since GeneDesign was …See details»
GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens
Apr 8, 2019 Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that GeneDesign, Inc. has joined the global organization.See details»